New RNA & DNA-sequencing platform matches thousands of drugs to late-stage cancer patients
(New York, NY - Aug. 8, 2018) -- A comprehensive RNA and DNA sequencing platform benefits late-stage and drug-resistant multiple myeloma patients by determining which...








